Related Experiment Video
Updated: Jun 7, 2025

Calcification of Vascular Smooth Muscle Cells and Imaging of Aortic Calcification and Inflammation
Published on: May 31, 2016
Atherosclerosis, vascular calcification and osteoporosis
Carmen Valero1, Jesús González Macías2
1Hospital Marqués de Valdecilla, Instituto de Investigación Valdecilla (IDIVAL), Santander, Cantabria, España; Universidad de Cantabria, Santander, Cantabria, España.
Bone loss and vascular calcification are linked, suggesting shared causes between osteoporosis and atherosclerosis. Treatments for one condition may impact the other, highlighting the interconnectedness of bone and cardiovascular health.
Area of Science:
- Cardiovascular Science
- Bone Biology
- Pathophysiology
Background:
- Epidemiological studies reveal a strong association between bone loss (osteoporosis) and vascular calcification, a hallmark of cardiovascular disease.
- Osteoporosis and atherosclerosis, a major cause of cardiovascular events, share common risk factors.
- The shared risk factors suggest overlapping pathogenic mechanisms underlying both bone and vascular diseases.
Purpose of the Study:
- To explore the interconnectedness of bone and cardiovascular health.
- To investigate the potential for shared pathogenic mechanisms between osteoporosis and atherosclerosis.
- To examine the bidirectional impact of treatments for osteoporosis and cardiovascular disease on each other's respective conditions.
Main Methods:
- Review of epidemiological data linking bone mineral density and vascular calcification.
- Analysis of shared risk factors for osteoporosis and atherosclerosis.
- Examination of pharmacological effects of osteoporosis and cardiovascular drugs on bone and vasculature.
Main Results:
- Consistent epidemiological evidence links reduced bone mineral density with increased vascular calcification and cardiovascular disease.
- Identification of shared risk factors, including aging, inflammation, and metabolic disturbances, implicating common pathogenic pathways.
- Potential for therapeutic interventions in one disease to adversely or beneficially affect the other.
Conclusions:
- Osteoporosis and atherosclerosis are not isolated conditions but are intricately linked through shared risk factors and pathogenic mechanisms.
- Therapeutic strategies for osteoporosis may influence cardiovascular risk, and vice versa.
- Further research is warranted to elucidate these complex interactions and develop integrated treatment approaches.
Related Concept Videos
Bone Disorders
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Role of Vitamins in Maintaining Bone Health
Vitamin A
Vitamin A is involved in the process of bone remodeling. Retinoic acid, the active metabolite of Vitamin A, has nuclear receptors in osteoblasts and osteoclasts, which are involved in bone remodeling.
Vitamin B12
Vitamin B12 acts as a cofactor during the formation of osteoblast-related proteins, such as osteocalcin. Vitamin B12 plays a role...
Hormones and Bone Tissue
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Osteoclasts in Bone Remodeling
Skeleton and Calcium Homeostasis
Bone Remodeling

